Clinical trial
A Prospective, Open-label, Multicenter, Post-market Study Evaluating Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds
NCT03050710 is registered in ClinicalTrials.gov with Croma-Pharma GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Open-label, Multicenter, Post-market Study Evaluating Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds
- Lead sponsor
- Croma-Pharma GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 27, 2016
- Completion date
- October 17, 2017
- Enrollment
- 62 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
nasolabial fold, hypoplastic